西亚试剂优势供应上万种化学试剂产品,欢迎各位新老客户咨询、选购!

登录

¥0.00

联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com

西亚试剂 —— 品质可靠,值得信赖

西亚试剂:Aging Hematopoietic Stem Cells Decline in Function and Exhi

Stuart M. Chambers1,2, Chad A. Shaw2,3, Catherine Gatza1,4, C. Joseph Fisk3, Lawrence A. Donehower1,4,5, Margaret A. Goodell1,2,3,6*

1 Program for Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America, 2 Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Texas, United States of America, 3 Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America, 4 Department of Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America, 5 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America, 6 Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America

Age-related defects in stem cells can limit proper tissue maintenance and hence contribute to a shortened lifespan. Using highly purified hematopoietic stem cells from mice aged 2 to 21 mo, we demonstrate a deficit in function yet an increase in stem cell number with advancing age. Expression analysis of more than 14,000 genes identified 1,500 that were age-induced and 1,600 that were age-repressed. Genes associated with the stress response, inflammation, and protein aggregation dominated the up-regulated expression profile, while the down-regulated profile was marked by genes involved in the preservation of genomic integrity and chromatin remodeling. Many chromosomal regions showed coordinate loss of transcriptional regulation; an overall increase in transcriptional activity with age and inappropriate expression of genes normally regulated by epigenetic mechanisms was also observed. Hematopoietic stem cells from early-aging mice expressing a mutant p53 allele reveal that aging of stem cells can be uncoupled from aging at an organismal level. These studies show that hematopoietic stem cells are not protected from aging. Instead, loss of epigenetic regulation at the chromatin level may drive both functional attenuation of cells, as well as other manifestations of aging, including the increased propensity for neoplastic transformation.

 Figure 1.Aging HSC Phenotypes and Functional Alterations

(A) Hoechst dye efflux by HSCs results in a SP (boxed) when viewed at two emission wavelengths. Comparison of the proportions of Sca-1–enriched SP cells from C57Bl/6 mice at 2 and 21 mo of age shows an approximate 9-fold increase with age.

(B) Expression of the two canonical stem cell markers, c-Kit and Sca-1, does not change significantly between 2 and 21 mo of age within the lineage-negative (Lin) SP population, indicating the SP cells remain remarkably phenotypically pure and homogeneous.

(C) Cell cycle analysis by propidium iodide staining of 2- and 23-mo-old HSCs purified on the basis of SParKLS.

(D) Limiting dilution functional assay of HSCs. In competitive repopulation experiments, there was little difference in HSC activity 4 wk after transplantation in young versus old HSCs. However, at 8 and 16 wk post-transplantation, 21-mo-old HSCs showed a reduced contribution compared to 2-mo-old control HSCs, depending on the donor cell dose (a single asterisk [*] indicates p 0.03; double asterisks [**] indicate p 0.09). Error bars represent one standard error.